AstraZeneca
-
AstraZeneca Revises Data on Vaccine Potency Amid Backlash, Says Candidate Still Holds Up
AstraZeneca updated its data late Wednesday on the effectiveness of its coronavirus vaccine candidate amid U.S. concern about misleading data,…
Read More » -
Safety Board Wary of AstraZeneca’s COVID Vaccine Trial Data
An independent review board has cast doubt on the findings for AstraZeneca's coronavirus vaccine candidate, saying the drugmaker's efficacy claims…
Read More » -
AstraZeneca Says Vaccine 100% Effective Against Severe COVID: ‘No Increased Risk’ of Blood Clots
AstraZeneca's coronavirus vaccine candidate has shown 79% efficacy against symptomatic disease and 100% efficacy against severe illness and hospitalization, the…
Read More » -
AstraZeneca’s Coronavirus Vaccine Shows Promising Results Among Elderly
British drugmaker AstraZeneca said Monday that its coronavirus vaccine has generated a similar immune response in older and younger adults…
Read More » -
COVID-19 Vaccine Won’t Work Unless Enough People Take It: Fauci
Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases and a member of the White House…
Read More » -
Americans Won’t ‘Pay a Dime’ for COVID-19 Vaccine: HHS Official
Paul Mango, deputy chief of staff for the Department of Health and Human Services, said Wednesday no American will have…
Read More » -
Nine Drugmakers Sign Safety Pledge for COVID-19 Vaccine
Nine biopharmaceutical firms vowed Tuesday not to seek premature government approval for a coronavirus vaccine and signed a pledge to…
Read More » -
Studies: Widely Used Diabetes Drugs Seem Safe for the Heart
MARILYNN MARCHIONE, AP Chief Medical Writer Some widely used diabetes medicines help control blood sugar without the heart risks suggested…
Read More » -
Billions of Dollars Spent on Cancer Medicines, Consultations and Diagnostic Tests Across the Globe
(The Times-Gazette) – According to a report on worldwide trend a staggering $100 billion is spent annually on cancer…
Read More » -
AstraZeneca, Shire Dive as U.S. Tax Move Punctures Deal Hopes
(Reuters) – Shares in drugmakers AstraZeneca (AZN.L) and Shire (SHP.L) fell sharply on Tuesday after the U.S. Treasury took…
Read More »
